A single arm, multicenter, phase II trial of oxaliplatin plus capecitabine in the perioperative treatment of locally advanced gastric adenocarcinoma in combination with D2 gastrectomy (NEO-CLASSIC)

被引：0
|
作者：
Tianshu, L. [1 ]
Yu, Y. [1 ]
Sun, Y. [2 ]
Min, Y. [3 ]
Cao, H. [4 ]
Yingbin, L. [5 ]
Wang, Y. [1 ]
机构：
[1] Fudan Univ, Zhongshan Hosp, Med Oncol, Shanghai, Peoples R China
[2] Fudan Univ, Zhongshan Hosp, Dept Gen Surg, Shanghai, Peoples R China
[3] Shanghai Jiao Tong Univ, Shanghai Ruijin Hosp, Dept Gen Surg, Coll Med, Shanghai, Peoples R China
[4] Shanghai Renji Hosp, Dept Gastrointestinal Surg, Shanghai, Peoples R China
[5] Shanghai Jiao Tong Univ, Xinhua Hosp, Dept Gen Surg, Sch Med, Shanghai, Peoples R China
来源：
ANNALS OF ONCOLOGY | 2016年 / 27卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
229P
引用
收藏
页数：1
相关论文
共 50 条
  • [11] Adjuvant capecitabine plus oxaliplatin after D2 gastrectomy in Japanese patients with gastric cancer: a phase II study
    Fuse, Nozomu
    Bando, Hideaki
    Chin, Keisho
    Ito, Seiji
    Yoshikawa, Takaki
    Tsuburaya, Akira
    Terashima, Masanori
    Kawashima, Yoshiyuki
    Fukunaga, Tetsu
    Gotoh, Masahiro
    Emi, Yasunori
    Yoshida, Kazuhiro
    Oki, Eiji
    Takahashi, Seiji
    Kuriki, Hiroshi
    Sato, Kumi
    Sasako, Mitsuru
    GASTRIC CANCER, 2017, 20 (02) : 332 - 340
  • [12] Adjuvant capecitabine plus oxaliplatin after D2 gastrectomy in Japanese patients with gastric cancer: a phase II study
    Nozomu Fuse
    Hideaki Bando
    Keisho Chin
    Seiji Ito
    Takaki Yoshikawa
    Akira Tsuburaya
    Masanori Terashima
    Yoshiyuki Kawashima
    Tetsu Fukunaga
    Masahiro Gotoh
    Yasunori Emi
    Kazuhiro Yoshida
    Eiji Oki
    Seiji Takahashi
    Hiroshi Kuriki
    Kumi Sato
    Mitsuru Sasako
    Gastric Cancer, 2017, 20 : 332 - 340
  • [13] Perioperative penpulimab plus anlotinib combined with chemotherapy for locally advanced gastric cancer: A single arm, multicenter, phase II clinical trial.
    Wang, Mian
    Zhou, Wei
    Miao, Yan
    Tan, Zhaobang
    Li, Yiding
    Hong, Liu
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 : TPS485 - TPS485
  • [14] Overall survival of perioperative or postoperative adjuvant oxaliplatin with S-1 versus adjuvant oxaliplatin with capecitabine in locally advanced gastric or gastrooesophageal junction adenocarcinoma undergoing D2 gastrectomy: An updated analysis of RESOLVE trial
    Zhang, X.
    Li, Z.
    Liang, H.
    Xue, Y.
    Wang, Y.
    Zhou, Z.
    Yu, J.
    Chen, L.
    Du, Y.
    Li, G.
    Xiao, G.
    Wu, D.
    Zhou, Y.
    Dang, C.
    He, Y.
    Zhang, Z.
    Sun, Y.
    Li, Y.
    Shen, L.
    Ji, J.
    ANNALS OF ONCOLOGY, 2023, 34 : S1318 - S1319
  • [15] Adjuvant capecitabine and oxaliplatin for gastric cancer after D2 gastrectomy (CLASSIC): a phase 3 open-label, randomised controlled trial
    Bang, Yung-Jue
    Kim, Young-Woo
    Yang, Han-Kwang
    Chung, Hyun Cheol
    Park, Young-Kyu
    Lee, Kyung Hee
    Lee, Keun-Wook
    Kim, Yong Ho
    Noh, Sang-Ik
    Cho, Jae Yong
    Mok, Young Jae
    Kim, Yeul Hong
    Ji, Jiafu
    Yeh, Ta-Sen
    Button, Peter
    Sirzen, Florin
    Noh, Sung Hoon
    LANCET, 2012, 379 (9813): : 315 - 321
  • [16] A multicenter phase II trial of perioperative capecitabine plus oxaliplatin for clinical stage III gastric cancer (OGSG1601)
    Kawabata, R.
    Terazawa, T.
    Matsuyama, J.
    Endo, S.
    Shiraishi, O.
    Fujita, S.
    Akamaru, Y.
    Taniguchi, H.
    Tatsumi, M.
    Gotoh, M.
    Lee, S-W.
    Kurokawa, Y.
    Shimokawa, T.
    Sakai, D.
    Kato, T.
    Fujitani, K.
    Satoh, T.
    ANNALS OF ONCOLOGY, 2018, 29 : 226 - 226
  • [17] Neoadjuvant docetaxel, oxaliplatin plus capecitabine versus oxaliplatin plus capecitabine for patients with locally advanced gastric adenocarcinoma: long-term results of a phase III randomized controlled trial
    Tian, Yuan
    Yang, Peigang
    Guo, Honghai
    Liu, Yang
    Zhang, Ze
    Ding, Pingan
    Zheng, Tao
    Deng, Huiyan
    Ma, Wenqian
    Li, Yong
    Fan, Liqiao
    Zhang, Zhidong
    Wang, Dong
    Zhao, Xuefeng
    Tan, Bibo
    Liu, Yu
    Zhao, Qun
    INTERNATIONAL JOURNAL OF SURGERY, 2023, 109 (12) : 4000 - 4008
  • [18] Efficacy and safety of cadonilimab and COX-2 inhibitor combined with oxaliplatin and capecitabine (XELOX) in perioperative treatment for locally advanced resectable gastric adenocarcinoma: A prospective, single-center, randomized, phase II trial
    Qian, Y.
    Zhai, E.
    Ye, J.
    Chen, S.
    Yuan, K.
    Wang, Z.
    Xu, J.
    Zhang, X.
    Ma, J.
    Chen, C.
    Peng, J.
    Chen, J.
    Cai, S.
    ANNALS OF ONCOLOGY, 2024, 35 : S196 - S196
  • [19] PHASE I/II TRIAL OF PERIOPERATIVE OXALIPLATIN (O), CAPECITABINE (C) AND IRINOTECAN (I) FOR PATIENTS (PTS) WITH LOCALLY ADVANCED GASTRIC CANCER
    Utelbayeva, A.
    Arzykulov, Z.
    Izhanov, E.
    ANNALS OF ONCOLOGY, 2010, 21 : 45 - 46
  • [20] Phase II trial of oxaliplatin plus capecitabine as first-line treatment in patients with advanced gastric cancer (AGC)
    Palumbo, R.
    Bernardo, A.
    Strada, M. R.
    Poggi, G.
    Teragni, C.
    Delmonte, A.
    Frascaroli, M.
    Jedrychowska, I
    Canto, A. M.
    Bernardo, G.
    ANNALS OF ONCOLOGY, 2006, 17 : XI51 - XI52
12345